Twentieth session of the Joint Action Forum (JAF20), Addis Ababa, December 2014: final communique

WORLD HEALTH ORGATIIZATION AFRTCATT PROGRAMMEME FOR ONCHOCERCTASTS CONTROL (APOC) Twentieth Session ofthe Joint Action Forum Addis Ababa, Ethiopia, 08 - 09 December 2014 F'INAL COMMUNIQUE Thematic Area 1 - Opening of the Session & Election of officers l. The twentieth session of the Joint Action Forum (JAF) of the African Programme for Onchocerciasis Control (APOC) was hosted by the Ethiopian Government, from 08 49 December 2014 in Addis Ababa, Ethiopia. The meeting was attended by Honourable Ministers or their representatives of 24 onchocerciasis-endemic countries in Africa, l0 representatives of the donor community, the World Bank, the African Development Bank, WHO (Headquarters, AFRO, Country Office/Ethiopia), senior health managers, Non-Govemmental Development Organizations (NGDOs), the Mectizan Donation Programme, Merck & Co. Inc., Research Institutions, Directors and Coordinators of National Onchocerciasis Conrol Programmes, and Representatives of the Statutory Bodies of APOC. The list of participants is appended as annex l. 2. Welcoming speeches and opening remarks were given by the WHO Representative in Ethiopia, Dr Pierre M'Pdl6, APOC Director, Dr Jean-Baptiste Roungou; outgoing Chair of JAFI9 and the Minister of Health and Population, Republic of Congo, Honourable Mr. Francois Ibovi represented by Dr Damase Bodzongo. There were also statements by the Executive Secretary of the Global Alliance for the Elimination of Lymphatic filariasis (GAELF), Dr Adrian Hopkins, and the Senior Programme Offrcer, Bill & Melinda Gates Foundation (BMGF), representing Uniting to Combat NTDs, Dr Julie Jacobson. The Ethiopian Federal Minister of Health, Dr Kesete-Birhan Admasu, gave the opening speech. On behalf of the govemment of Ethiopia, the Minister of Health declared the meeting open. 3. The JAF elected the Federal Minister of Health, Ethiopia, in the person of Dr Kesete-Birhan Admasu as Chair of JAF20, and Dr Julie Jacobson as Vice Chair. The Chair of JAF20 thanked the session for his election, and congratulated the outgoing Chair, Honourable Mr. Francois Ibovi from Republic of Congo for steering JAF in the past 12 months. 4. Reflections of the Committee of Sponsoring Agencies (CSA): The reflections of the CSA were presented by its Chair, Dr Lucien Manga. He noted that the forthcoming closure of APOC and the concomitant creation of a new entity are challenges that should be taken up by APOC and the CSA. The CSA Chair said that the declaration made on 6 December 2014 atthe 1496 session of the CSA by the WHO Assistant-Director General, Dr Hiroki Nakatani, on behalf of WHO, was welcomed by all the participants who considered it as a consensual basis of work regarding the closure of APOC and the launching of PENDA. Twentieth Session ofthe Joint Action Forum pAF20), Addis Abobo, December 2074 1 Thematic Area2 - Progress on Elimination and Country Reports 5. JAF received presentations on the WHO Progress report (lst September 2013- 3lst August 2014), the Technical Consultative Committee activities, as well as summaries of treatments and trainings in 2013. Key highlights of the presentations included the treatnent of over 100.6 million persons in 24 countries; thetraining of 73l,l2l CDDs and 106J28 health workers; as well as various activities conducted by APOC Management and TCC. JAF was informed that outcomes of epidemiological evaluation suggest that transmission has been intemrpted in Burundi, Chad, Malawi, Mali, Niger and Senegal and that there are focal elimination in Benin, Burkina Faso, CAR, Congo, Cote d'Ivoire, Ethiopia, Nigeri4 Tanzania and Togo, while in Uganda transmission of onchocerciasis infection has been intemrptd in 12 out of 16 districts where the disease has previously been endemic. These findings remain to be confirmed by repeated surveys and post treatment surveillance. 6. Ministers of Health and heads of delegations from countries made statements that expressed their renewed efforts, achievements, challenges and way forward in the elimination of onchocerciasis and other neglected tropical diseases in their respective countries. 7. The JAI session also received a presentation from the NGDO Coordination Group for Onchocerciasis Elimination which highlighted the Group's financial and technical contributions to onchocerciasis elimination. Conclusions on Progress of Elimination: 8. JAF commended APOC Management, TCC and the countries for lucid presentations and statements. The Forum noted that some countries are showing good epidemiological evaluation results indicating elimination of onchocerciasis infection which needs to be confirmed by entomological evaluation and post freafinent surveillance surveys. 9. The Forum noted the strong endorsement for PENDA as a new strategy and support to onchocerciasis and lymphatic filariasis elimination and other NTDs controVelimination activities by countries. It recognized the need to maintain the momentum and build on the achievements ofAPOC when transiting to PENDA. Thematic Area 3 - Preparation for PENDA and Closure of APOC 10. JAF received a presentation on the road map for the establishment of PENDA from the CSA Chair who gave the guiding principles for the management of the transition as follows: closure of APOC and establishment of PENDA are two independent processes taking place simultaneously, the decision making bodies are separate (JAF for APOC closure, WHO for convening a meeting for PENDA, and CSA will act as "interim steering committee" for PENDA establishment). On the closure of APOC, the CSA Chair stated that WHO had indicated that an interdisciplinary team will be established immediately for programme and staff issues but APOC operations will need to be maintained and managed through the end of 2015. Meanwhile, he noted that funding for programme closure will need to be confirmed. The final closure and celebration of achievements will be at JAF2I in December 2015. On the formation of PENDA, the CSA Chair indicated that background and discussion documents will be drafted by WHO based on previous work and approved conce,pt note and strategic plan. He also said that a group of representatives of constituencies will review and clear the documents after which high-level advocacy will be taken with stakeholders and donors to get support for the plan and budget. Furthermore he said a stakeholders' consultation with countries, Twentieth Session of the Joint Action Forum (JAF20), Addis Abobo, December 2074 2 ll. partners, and donors in a sort of "pre-forum" will take place in June 2015, convened by WHO. JAF was informed that the estimated cost for the closure of APOC will be 36 million USD. The Representative of the fiscal agent presented an overview of the funding for OCP and APOC. Alrnost US D 1.2 billion has been channelled through the Trust fund since OCP and there have not been any fiduciary mishaps. The cash flow analysis from the World Bank projects a funding shortfall for 2014 of USD 364,604, if all donors respect their pledges. In 2015, it is estimated that the closure of APOC will require an estimated USD 17,000,000 for the worst case scenario and with a flat operational budget of USD l9 million, hence about USD 36,000,000 is required. However, pledges of USD 8,666,635 have been made and a cushion amount of USD 15,000,000 is available, amounting to USD 23,666,635.I1 is recommended that these resources be used to pay for APOC staff salaries (Estimated at USD 8,000,000 of the USD 19,000,000) and the closure for APOC. As and when more funds become available, they should be used for the implementation in 2015. It is worth noting that at the time of planning, it was assumed that all the partners will respect their pledges but this has not been the case. By the time of the twentieth Joint Action Forum (JAF20), we had a shortfall of USD 17,800,000. If these pledges were respected, it will be possible to implement activities as planned. The World Bank updated the participants about a pledge for Onchocerciasis elimination within the new entity- PENDA of USD 0.75 million. The constituent groups of JAF went into closed door sessions to discuss the road map for closure of APOC and the establishment of PENDA as well as the priority activities of PENDA. These groups presented to JAF their suggestions. The Ministers noted that there is a funding gap to APOC activities in 2015 and yet there is need to maintain the momentum and work towards elimination of NTDs as planned. They emphasized that PENDA should build on the successes of APOC and leam from its weaknesses. Based on this background, Ministers resolved as follows: i) On closure of APOC and establishment of PENDA: a. APOC should close by 3 I't December 20 15 as earlier agreed and PENDA established. b. WHO should be the executing agency for PENDA. c. The CSA should furalize the legal documentation for the establishment of PENDA and staffrequirement as soon as possible. d. WHO should consider retaining the critical APOC staff and re-assign them to PENDA or other programmes as appropriate. This will guide the planning/budgeting process for 2015 operations and some funds would be saved from closure staffcosts. e. APOC should revise the 2015 activities based on the available APOC Trust funds. The revised activity plan and budget should be communicated to countries so that countries mobilise more resources intemally where necessary. f. Countries should take additional responsibility for the control and elimination of NTDs in 2015 and should use the existing mechanisms to integrate NTDs into health systems so as to continue with the momentum realized by APOC. ii) On the prioritv activities for PENDA: a. PENDA should play a technical leadership and coordinating role with decisions decentralized and bulk of the activities implemented at country level so as to reduce overhead costs. Twentieth Session ofthe toint Action Forum (tAF2O), Addis Abobo, December 2074 3 12. 13. c. d. e. PENDA should facilitate the procurement of donated medicines for all Preventive Chemotherapy (PCT) NTDs. PENDA should operate an incentive funding/counterpart financing mechanism to ensure govemments increasing responsibility for programme implementation. This is without prejudice to its investments on personnel. PENDA should work on strengthening health systems. PENDA should focus on all PCT NTDs and NOT only Onchocerciasis and Lymphatic Filariasis and continue to assist countries in implementation of MDA and surveillance. The NGDO group after the review of the issues stated as follows: i) On closure of APOC: a. First and foremost, there is need to stop MDA at national level somewhere with fanfare and thereby prove the validity of the APOC plan of oncho elimination. But stopping MDA activities will have cross border issues; for example, extra surveillance in border areas which need to be considered. b. Great concem wix expressed about the $ll million shortfall. The Group called for an immediate review of projects most dependent on APOC funds to maintain coverage. Those projects should get priority available funding. A Project by Project, Country by Country analysis, with NOTF review or input is needed as soon as possible. c. Countries and NGDO partners should take on more costs. d. The closure of APOC is largely a WHO administrative issue. The group however notes that this process will be disruptive in terms of employees. ii) On the priority activities of PENDA in 2016 the Group noted as follows: a. There were two divergent views on the overall focus of PENDA: continue to focus on LF and Oncho or encompass all the PC-NTDs. b. The NGDOs were interested here in what countries want and what donors will fund. Based on the anticipated annual budget of PENDA, activities listed in the current PENDA document should be prioritized and supported in order of priority. c. Staffurg up PENDA will be needed especially if the skill sets needed involve other NTDs (STH, SCH, TRA) not originally contemplated in detail in the current plan. d. If restricted to LF and Oncho, with bringing other PCT NTDs on more slowly, there was still concem that PENDA under a restricted budget would not take off in 2016 as the elimination champion of LF and oncho. But given current financial realities, making do with a small budget and demonstrating success to donors could result in increasing budgets over time when value for money is better recognized; then more activities could be brought on, again in order of priority. The donors proposed as follows: i) To APOC: a. Pledges are at risk and may not be honoured if activities are not carried out in 2015. Funds from donors are given for activities and associated with deliverables and it will be unacceptable to have no activities in 2015. b. APOC should focus on documenting success for closure and prepare and archive the historic data and lessons leamed for transition to the new entity. Twentieth Session ol the Joint Action Forum AAF20), Addis Abobo, December 2O74 4 b. 14. 15. c. Provide clarification on closure costs including what are fxed costs. The costs of retirement etc. for former staff on page 22 of the furancial report for the year ended 2013 should not be a liability for the project and the Trust Fund. ii) To WHo (HO. AFRO. & APOC): a. WHO is expected to actively work to reduce redundancy costs so that savings could go towards prograrnme activities in 2015. b. The group endorses the plan to get the new entity (PENDA) defined as soon as possible in order to maintain current donors and atfiact more donors to the NTD area. c. If WHO can ensure the availability of an endorsed plan for the regional entity within the next three months, donors are willing to actively engage and even advocate for resources.d. The new regional entity should support national programmes and explore new ways of working with countries to improve prograrnme ownership. iii) To countries: a. Donors need to understand the potential gaps for 2015. The Mectizan Donation Program will be calling partners together to reduce these gaps in mass drug administration during the transition 2015 - 2016. Donors are committed to working with countries to help to the besiof their ability to ensure there are no gaps in MDA in the transition time from 2015-2016. Co nclusions on Preparation for PENDA : 16' JAF expressed its appreciation to the APOC constituent groups for the suggestions, thoughts and clarifications and urged that they should be seriously considered in closing APOC, "rtubtishingPENDA and determining the priority activities of pENDA in20t6. Thematic Area 4 - Programme Management and Finance 17. The external auditors'report was provided to JAI. 18. Representatives of the various donors at the meeting made statements on their support for the elimination of onchocerciasis and other neglected tropical diseases in the context of Ap6C, PENDA and direct country support. Such statements were received from ADB, BMGF, CNTD/Liverpool, END Fund, France, GNNTD, GSII Japan Embassy, Merck & co. Inc., MIToSATH, NGD9 Coalition, Kuwait Fund, Sightsavers, USAID and World Bank. Conclusions on Programmc Managemcnt and Finance: 19. The Forum took note of the Auditor's report. JAF thanked the donors and NGDO partners for their renewed commitment and support. Thematic Area 5 - JAF Recommendations 20. Based on the presentations, discussions and conclusions reached during the meeting, JAF made the following recommendations : Twentieth Session ofthe lointAction Forum pAF20), Addis Abobo, December 2074 5 To IVHO: a. PENDA should focus on all PC-NTDs while remaining committed to the goal of achieving elimination of Oncho and LF and should recruit staff with relevant expertise across all the PC- NTDs. The road map for PENDA should clearly reflect among its priorities support for MDA implementation, the facilitation of the timely approval of applications of NTD medicines, support foi MDA, and building capacity of endemic countries for monitoring and evaluation and for post treatment surveillance. The original scenario of launching PENDA with full coverage for onchocerciasis and lymphatic filariasii should be reviewed given the very low reported coverage of LF for 2013 and the plan revised accordingly. WHO should eniure the availability of an endorsed plan according to the road map presented for the establishment of the new regional entity by March 15, 2015 to enable donors to actively engage and advocate for resources. To Countries: DRC and Liberia are commended for the CDDs contribution in containing the Ebola crises' JAF called on countries to strengthen their health systems to address such challenges and ensure MDAs are resumed when prudent. JAF urge DRC and Liberia to share their experiences in publication for the benefit of other countries. Given the wide anay of partners supporting NTD interventions, Member-States should ensure improved coordination at national level. Countries should take additional responsibilities for the control and elimination of NTDs and utilize existing mechanisms to integrate NTDs into health systems to ensure the momentum created by APOC is maintained. d. Countriei should make available to donors the potential gaps for 2015 so that gaps in mass drug administration during the transition 2015 - 2016 can be reduced. To Partners: Partners in consultation with countries should support in filling MDA gaps in 2015 and at the early stages of PENDA to ensure that current gains are maintained. Partners should harmonize their support at country level for better synergies in line with the NTD Master Plans. JAF Decisions 21. JAF made the following decisions: a. The road map for development of PENDA as presented by cSA is accepted. b. ApOC should close by jl"December 2015 but should continue operations and support for MDA prior to its closure, aligning activities with available funds in 2015, prioritizing MDA. c. APOC should revise the 2bl5 activities and communicate to countries so that countries mobilise more resources internally where necessary, prioritizing MDA. d. PENDA should be established beginning from January 2016. The CSA should finalize the legal documentation for the establishmint of pBNOe and staff requirements determined by WHO by March 15, 2015. e. The new regional entity while having a bigger and long-term vision that includes all PC-NTDs should be leaner and country-led in its operations. Twentieth Session ol the Joint Action Forum (JAF20), Addis Abobo, December 2O74 6 b. b. b. f. Noting that some 2013 treatnent data are not yet collected, APOC Management should update its data base and share with JAF participants by March 2015, and work to improve timely data reporting. g. APOC should ensure all curent and historic data is available after the closure of the programme. Date and Place of the 21"tJAF session 22. The 2l$ session of JAF will be held in the second week of December 2015. The venue will be communicated at a later date after further consultation by APOC Management with the Chair of JAI20 and the Chair of the CSA. Closure 23. JAF thanked the Ethiopian Government for hosting JAF20 and for the warm hospitality extended to participants. Twentieth Session olthe JointAction Forum (!AF20), Addis Abobo, December 2074 7 Annex 1 African Programme for Onchocerciasis Control (APOC) Programme africain de lutte contre I'onchocercose JOINTACTIONFORUM JAF-FAC FORUMD'ACTIONCOMMUNE Office of the Chairman Bureau du Pr6sident JOINT ACTION FORUM Twentieth session ORIGINAL: ENGLISH Addis Ababa. Ethiopia. 08-09 December 2014 December 2014 LIST OF PARTICIPAI\T S/LISTE DES PARTICIPAI\IT S APOC COUNTRIES/PAYS APOC Angola 0l . Dr Adelaide de Carvalho, Directrice Nationale de la Sant6 Publique, Ministdre de la Sant6, Rua Congressodo Mpla No 67 C.P.l20l, Luand4 Republique de l'Angola -TeL.244 923 641093 /244 222330 435 Fax :+244222330435 -Email: laide6T@hotmail.com; tampana@gmail.com Burkina Faso 02. Mr Amidou TOURE, Ambassadeur, Ambassade du Burkina Faso, Addis Ababa, Ethiopia Tel. 0333962832 - Email : amidou.toure@gmail.com 03. Dr Frangois DRABO, Coordonnateur du Programme national de lutte confe les maladies tropicales n6glig6es, Direction de la lutte contre la Maladie, Ministdre de la Sant6, 03 BP 7009, Ouagadougou 03, Burkina Faso - Tel: +226 70 69 43 48 - E-mail: drabofranck@yahoo.fr 04. Dr Windtar6 Roland BOUGMA, Coordonnateur du Programme national d'6limination de la filariose lymphatique, 03 BP 7009 Ouagadougou 03, Burkina Faso - T6l : 70 27 03 33 - E-mail : wro landbou gma@yah oo. fr Burundi 05. Dr Sabine NTAKARUTIMANA, Ministre de la Sante Publique et de la lutte contre le SIDA, Ministdre de la Sant6 Publique et de la lutte contre le SIDA - Fax:257 22229196 -Tel.:257 2222 91 95 - Email : ntakarutimana2006@,vahoo.fr 06. Dr On6sime NDAYISHIMfYE, Directeur du PNMTNC, Ministdre de la Sant6 Publique et de la lutte contre le SIDA, Fax:257 22229196 - TeL257 7991 0036 - Email : ndavones@yahoo.fr Twentieth Session ofthe JointAction Forum (JAF20), Addis Ababo, December 2074 8 07. 0E. Ms Rosine KANEZA, Assistante du Ministre (Charg6e des questions juridiques), Ministdre de la Santd Publique et de la lutte contre le SIDA, Fax :257 2222 9196 - Tel. 257 22229195 -Email: kanezarosine@)zahoo. fr Mr Janvier NDYABANIRWA, Chef de l'Unite, suivi, 6valuation, 6pid6miologie et recherche, Ministdre de la Sant6 Publique et de la lutte contre le SIDA, Fax 257 2222 9196 - Tel.257 7773 1979 - Email : banirwa@yahoo.fr Cameroon/Cameroun 09. Monsieur Hayatou ALM, Ministre Secr6taire d'Etat d la Santd au Ministdre de la Sant6 Publique, chargd de la Lutte contre les 6pid6mies et les pand6mies, BP 155, Yaound6, Cameroun -TeL.237 222225799 - Email : alimhayatou@,vahoo.fr 10. Dr Benjamin Didier BIHOLONG, Coordonnateur du Programme National de Lutte contre l'Onchocercose, Secrdtaire Ex6cutif du GTNO, Ministdre de la Sant6, Yaound6, Cameroun - Tdl: + 237 679758660 / 699612800 - Portable: +237 99 61 28 00 - Fax: +237 22 22 44 19 - E-mail: biholons di@vahoo.fr Central African Republic I l. Dr Georges YAYA, Directeur du Programme nationalde Lutte contre les Maladies C6citantes, Ministdre de la Sant6 et de la Population, B.P. 586, Bangui, R6publique Centrafricaine - Tel: +236 75 50 58 85 - Email: geya@live.fr 12. Dr Benoit KEMATA, Ophtalrnologiste, Coordinateur National du PNLO, Ministdre de la Sant6 et de la Population, B.P. 1772, Bangul R6publique Centrafricaine, T6l (Cel) : (236) 70 40 26 Ol l(236)72 58 53 89 - E-mail: bkemata@yahoo.fr 13. Dr Bernard BOUA, M6decin Coordonnateur du Programme National de Lutte conte les Maladies Tropicales N6gligdes, Ministdre de la Santd et de la Population, Bangui, R6publique Centrafricaine - Tel. Tel: Q36) ?5 50 46 37 - (236) 70 93 25 75 - Email: bernard.boua@smail.com Chad 14. 15. 16. Dr Assane NGUEADOUM, Secr6taire d'Etat, Ministdre de la santd publique, B.p. 440, N'Djamena, Tchad - Fax 235 22 51 62 89 - Tel. 235 51 5t t4 - (Bur.) 235 22 52 32 66 - Email : Dr Mahamat Annour WADAK, Secr6taire G6ndral du Ministdre de la Sant6 Publique, BP 440 N'Djamena, Tchad - TEI : +235 66 26 07 87 - E-mail: wadakourak@yahoo.fr Monsieur Nadjilar LOKEMLA, Coordonnateur du Programme National d'6limination de l'Onchocercose et de la Filariose Lymphatique, Ministdre de la Sant6 Publique, B.P.405'1, N'Djamena, Tchad - Fa,r: +235 22 52 48 38 - Tel: +235 66 29 0l 64 - E-mail: nadiilar@yahooo.fr Twentieth Session ol the JointAction Forum (JAF20), Addis Abobo, December 2074 9 Congo 17. Dr Damase BODZONGO, Conseiller i la sant6 et au bien-6tre, Ministdre de la Sant6 et de la Population, BP 2101, Brazzaville, R6publique du Congo - Tel.00242 055364277 - Email: b ozongo_damase@yahoo.fr 18. Prof. OBENGUI, Directeur G6ndral de l'Epiddmiologie et de la Lutte contre les Maladies, Ministdre de la Sant6 et de la Population, BP 1066 Brazzaville, R6publique du Congo - T6l: 00 242 0555 63 544 - E-mail: obengui52@ymail.com C6te d'Ivoire 19. Prof. Yapo Fdlix BOA, Directeur G6n6ral de la Sant6, Ministdre de la Sant6 et de la lutte contre le SIDA, l3c'" 6tage de la Cit6 Administrative Tour C, Abidjan, BP V4, Abidjan 01, C6te d'Ivoire- T6l: +225 01256221- Mobile : +225 07 09 64 94 - E-mail: boa.felix@smail.com 20. Dr Amenan Marie Madeleine KOUAKOU EPSE ILUNGA, Directeur/Coordonnateur du Programme National de la Sant6 oculaire et de la Lutte contre le SIDA (PNSO-LO), 25 BP 299 Abidjan25,Cdted'Ivoire-T6l+225224437 01 -Mobile:+22507 083803 -Fax:+225 22.44.37 .83 - E-mail: maedy-koua@yahoo.fr 21. Dr Aboulaye MEITE, Directeur Coordonnateur du Programme National de Lutte contre la Schistosomiase, les Geo-hekninthiases et les Filarioses Lymphatiques (PNL-SGF), 06 BP 6394, Abidjan 06, C6te d'Ivoire - T6l: (225) 57 68 68 14 - Fax (225) 22 52 38 35 - E-mail : aboulaye meiteTT@yahoo.fr Democratic Republic of the Congo/R6publique Ddmocratique du Congo 22. Dr Benoit KEBELA ILUNGA, Directeur de la Lutte contre la Maladie, Ministdre de la Sant6 publique, 39, Avenue de la Justice, C/Gombe, Kinshasa, R6publique D6mocratique du Congo - Cellulaire: +243 99 99 72 691 - E-mail: kebelailunea@email.com 23. Dr Pitchouna AWACA UVON, Directeur du Programme National de Lutte contre l'Onchocercose, Ministdre de la Sante publique, 36, Avenue de la Justice, C/Gombe, Kinshasa, Rdpublique D6mocratique du Congo - Cellulaire: +243.81.78.22.566 - E-mail: pnlo rdc@yahoo.fr; n aop itchouna@.vahoo.fr 24. Dr Matakombo Joseph LINGUBA, Programme national de lutte contre la Filariose Lympathique (PNLFL) Ministdre de la santd publique, Kinshasa I, Kinshasa-Gombe, R6publique D6mocratique du Congo -TEl.: Qa\81rc26447 - E-mail: linsubajoseph@smail.com Ethiooia/Ethiopie ZS. Dr Kesetebirhan Admassu BIRHANE, Honourable Minister of Health, Federal Ministry of Health, P. O. Box 1234, Addis-Ababa, Democratic Republic of Ethiopia -Tel.25l I 51 70 ll Dsl I 15 96 BZ - Mobile (251)-911405484 - Fax 251 I 51 93 66 - Email:moh@.telecom.net'et; Keseteadmasu@vahoo.com; KeseteA@moh.eov.et Twentieth Session of the Joint Action Forum pAF20), Addis Abobo, December 2074 10 26. 27. 28. 29. 30. 31. 32. Dr. Abdissa KURKIE, Director, Disease Prevention and Control Directorate, Federal Ministry of Health, P.O. Box :1234 Addis Ababa, Ethiopia - e-mail: abdissak@gmail.com Mr Oumer Shafi ABDURAHMAN, Neglected Tropical Diseases Team Leader, Disease Prevention and control Directorate, Federal Ministry of health, p.o.Box 1234, Addis Abab4Ethiopia - Fax:0ll-515-9615 - Phone: +251912-048-181 - office:0115152054 -Email: oumeriaii@smail.com Mr Kadu Meribo BURIKA, NTDs Officer @ocal Point for Onchocerciasis & Lymphatic Filariasis), Federal Ministry of Health, P.o. Box 2t7lg/to}o - Addis Ababa, Ethiopia - Tel: +251 09ll 152926 - E-mail: meribokadu@gm ail.com Mr Abdu SALA, Federal Ministry of Health, P.O. Box 21718/IOOO - Addis Ababa, Ethiopia - Tel: +25r 09tt 766223 Mr Beleke MAMMO, Federal Ministry of Health, P.O. Box 21718/IOOO - Addis Ababa, Ethiopia - Tel: +251 09ll 934697 - Email: belekelg@yahoo.fr Mr Belhasnu ASFAW, Federal Ministry of Health, P.O. Box 21718/IOOO - Addis Ababa, Ethiopia -Tel: +251 09119?41632 Mr Abdissa Kurkie KABETO, Federal Ministry of Health, P.O. Box 2lTlSllOOO - Addis Ababa, Ethiopia- T el. +25 I 9 12 605 -590 - Email: Abd issa.kurkie@ gmail.com Gabon 33. Dr Julienne ATSAME, Directeur du Programme de Lutte contre les Maladies Parasitaires, Ministdre de la Sant6 Publique, BP 2434, Libreville, Gabon - Teli +Z4l 06 04 73 14 - E-mail: i ul ienneatsame@)rahoo.fr Ghana 34. Dr Nana-Kwadwo BIRITWUM, Programme Manager, Neglected Tropical Diseases Programme(NTD), Ghana Health Service, P.O. Box MB-190, Accra, Ghana - Tel: +233 20 923 22g6 _ Fax: +233 302228739 - E-mail: nkadbiritwum@gmail.com; nanakwadwo.biritwum@ghsmail.org 35. Dr Linda BATSA DEBRAH, Filariasis Projects Coordinator, Kumasi Centre for Collaborative Research (KCCR) into Tropical Medicine, Kumasi, Ghana, Tel: 00233 208174 Z44\OOZ33 322 060 35 I - E-mail: lindrousy@.yahoo.com Guinde Conakrv 36. Dr Roben CAMARA, Directeur National de la Prdvention et de la Sante Communautaire, Ministdre de la Sant6, BP 585, Conakry, Rdpublique Guin6e -TeL.22462293 13 92- Email: robertcam2 00 5 @yahoo. fr Twentieth Session ofthe toint Action Forum (JAF20), Addis Abobo, December 2074 LI 37. Dr Andr6 GOEPOGUI, Coordonnateur, Programme National de Lutte contre l'Onchocercose et la C6cit6/IvITN, Ministdre de la Sante, BP 585, Conakry, R6publique Guinde -Tel: +224622 518063 - E-mail: agoep@yahoo.fr Guin6e Bissau 38. Dr Cristovao MANruBA, Directeur de la Lutte conte les Maladies Transmissibles et Non Transmissibles, Ministdre de la Santd publique, Av. Unidade Africana, B.P. 50-1013, Bissau Codex - Tel. ; 245 555 l82l Cel.: 00245 662 l82l - E-mail: cristo-manjuba2000@),ahoo.com.br Kenya 39. Dr Dunstan Mukoko AKUMBI, National Coordinator, Program to eliminate Lymphatic Filariasis, Vector-Borne Diseases Control Unit, Ministry of Health, P.O. Box 20750 00202, Nairobi, Kenya - T el: +25 4 7 22 3 481 88 - -E-mai l: Dunstan.Mukoko2 9 @ gmail.com Liberia 40. Mr Karsor K. KOLLIE, Director, Neglected and Non Comminicable Diseases Program, Ministry of Health & Social Welfare, P.O. Box l0-9009, 1000 Monrovia 10, Liberia, West Africa - Tel.: 231 886532903 - Email: tanuel5@yahoo.com 41. Mr Anthony Kerkula BETTEE, Physician Assistant and National Onchocerciasis Coordinator, Neglected Tropical Diseases Program, Ministry of Health & Social Welfare, P.O. Box 10-9009' 1000 Monrovii 10, Liberia, West Africa _Tel: +23188 65 39 548 - E-mail: tbettee@yahoo'com 42. Ms Catherine THOMAS, National Schistosomiasis/STH Coordinator, Neglected Tropical Diseases Program, Ministry of Health and Social Welfare, P.O. Box 10-9009, 1000 Monrovia 10, Liberia -Tel.23l886 583 856 - Email: myworld.thomas29@gmail.com Malawi Dr Jean AlfazemaNachika KALILANI, Minister of Health, Ministry of Health, P.O. Box 3037'1, capital city, Lilongwe 3, MALAWI -Tel; +265178 9400 - Email: ia.kalilani@gmail.com Dr Stom KABULUZI, Director of Preventive Health Services, Ministry of Health, P.O. Box 30377, Capital City, Lilongwe 3, MALAWI - Tel.: +265 888 348 830 - Email: skabuluzi@Jahoo.com Mr Square MKWANDA, National Coordinator LF, Ministry of Health, P.O. Box 30377, Capital city, Lilongwe 3, Malawi - Tel.: +265 888854425 - Mob.: +265 8 854425 - Email: smkwanda@yahoo.com Mr Laston SITIMA, National Coordinator, NOCP, Ministry of Health, P.O. Box 30377, Capital city, Lilongwe, Malawi - Tel. (265) 888 303 446 - Fax: (265) 17 53 308 - E-mail: laston-sitima2000@yahoo. com Twentieth session ol the loint Action Forum (!AF20), Addis Abobo, December 2074 L2 43. 44. 45. 46. 47. 48. Ms Melia MAGANGA-NKHOMA, Director of Finance, Ministry of Health, p.o. Box 30377, capital city, Lilongwe, Malawi - Tel. (265) 888855085 - E-mail: mlmaganga@yahoo.com Mr Samuel JEMU, Ministry of Health, P.o. Box 30377, capital city, Lilongwe, Malawi - Tel. (26 5) I 7 5 243 4 - E-mail: Samuel j emu@.g ma i l.com Mali 49. Dr Mamadou Oumar TRAORE, Coordonnateur National du Programme National de Lutte contre l'onchocercose/DNS, 8.P.233 Bamako, Mali, T6l. Bureau :22j zz 64 g? - cel. :223 6 6 7l 17 66 - Fax: 223 20 233674 - E-mail : traoremot@yahoo.fr Dr Yaya Ibrahim COULIBALY, Coordonnateur de I'Unitd de Recherche sur les Filarioses, Facultd de Meddcine de Bamako, Magnambougou Rue 428, porte 92, Bamako, Mali - Tel. 223 66 74 2341- Email: vicoulibaly@icermali.org Mozambique 5l' Ms Odete PINTA ROXA, Ministry of Health, Maputo, Mozambique - Tel. 848161048258 -Email: odeteroxa@email. com Nigeria Dr Bridget OKOEGUALE, Director of Public Health, Departrnent of Public Health, Federal secretariat, Federal Ministry of Health, Abuja, Nigeria - Tel: +234 (o) go372ll52g - E-mail: bridgeclinic2002@yahoo.com Dr Yisa A. SAKA, National Coordinator Onchocerciasis and Lympathic Filariasis Elimination Programme, Federal Ministry of Health, Federal Secretariat, Shehu Shagari Way, Abuj4 Nigeria - Tdl/Tax: (234)9 5237049 - Mobile: 234 (0) Bo3 302 9387 - E-mail: yisaasaka@yahooiom - Dr Obiageli NEBE, Coordinator National Schistosomiasis/Soil Transmitted Helminths Conftol programme, Deparftnent of Public Health, Federal Ministry of Health, Abuja, Nigeria - Telephone :+23 4 -803 30 6003 6 - E-mail : neb eoj @yahoo. com Mr Emmanuel DAVIES, LF desk officer, Federal Ministry of Health, Federal Secretariat phase 3, 9ft Floor Room 909, Central District Area, Abuja, Nigeiia - Tel. +234(0)g033234635 - Email: enimed2003@vahoo.com South Sudan/Soudan du Sud 56. Dr Isaac Cleto Hassan RIAL, St ate Minister of Health, Western Bahr Al Ghazal State, Ministry of Health, Republic of South Sudan, Tel. +21 I 955496605 - Email: cleto.isaac@vahoo.com Twentieth Session of the JointAction Forum (LAF2O), Addis Abobo, December 2Ot4 13 50. 52. 53. 54. 55. 57. Mr Makoy Samuel Yibi LOGORA, National Coordinator, Onchocerciasis Confol/Elimination Programme, Ministry of Health, Republic of South Sudan - 2ll 955067144 - Email: morre lo gora@yahoo.com Sudan/Soudan 58. Dr Isameldin Mohammed ABDALLA, Undersecretary Federal, Federal Ministry of Health, Nile Avenue, Khartoum, Sudan - Email: isameldin99@yahoo.com 59. Dr Asam Mohamed Alli ZARROUG, Coordinator, National Onchocerciasis Control Programme, National Program for Prevention of Blindness, Federal Ministry of Health, Nile Avenue, Khartoum, Sudan - Fax: 0183 741422 - Tel: 0012499 230 61600 - E-mail: izanoug@yahoo'com 60. Dr Mousab S. ELIIAG, NTDs Director, National Health Laboratory, Federal Ministry of Health, Gasr Street, Khartoum, Sudan - Fax: 0183 741422 - Tel: 2499 12288269 - Email: mooosab33@yahoo.com Tarzaniaflar:r,anie 6l. Dr Stephen KEBWE, Deputy Minister of Health & Social Welfare, Ministry of Health and Social Welfare, 6 Samora Avenue, 11478, Dar-es-Salaam,Tanzania- Tel. +255 687 75 9829 - Mobile: 07846427 86 - Email: stephenkebwe@yahoo.com 62. Dr Neema RUSIBAMAYILA, Ag. Director Preventive Services, Ministry of Health and Social Welfare, 6 Samora Machel Avenue, 11478, P.O. Box 9083, Dar-es-Salaam, Tanzania - Phone: +255 254 866267 - E-mail: nrusibamayila@vahoo.co.uk 63. Dr Mwelecele MALECELA, Director Generat, National trnstitute for Medical Research (NIMR), Taw Zaw 10, Ministry of Health and Social Welfare, 3 Barack Obama Drive, Box 9653, Dar-es- Salaam lll0l, Tawania - Work phone: +255222121 400 2,55 228121360 - Mobile: +255 784 333 444 Fax: +255 22 2121360 E-mail: mwelentuli@gmail'com; mmalece la@hotmai l.com; mmalecela@nimr.or.tz 64. Dr Upendo John MWINGIRA, Program Manager, NTD control Programme, Ministry of Health & Social Welfare, , 6 Samora Machel Avenue, 11478, P.O. Box 9083, Dar-es-Salaam - Work phone: +255 222121376 - Mobile: +255 713 262 865 - Fa<: +255 222 l2l 360 - E-mail: umwinsira@vahoo.com 65. Dr Maria CHIKAWE, Programme Officer, Lymphatic Filariasis, Ministry of Health and Social Welfare, 6 Samora Machel Avenue, 11478, P.O. Box 9083, Dar-es-Salaam, Tanzania - Tel' +255 767 45 4475 -Fax:255 767 45 4475 - Email: chindallimaria@.gmail.com 66. Mr Oscar KAITABA, Programme Officer, Onchocerciasis, Neglected Tropical Disease Control programme, Ministry of Health and Social Welfare, 6 Samora Machel Avenue, 11478, Dar-es- Saliam, Taruania- Tel +(255) 784 88 93 90 /754 889 3901(255)- E-mail: ockaitaba@vahoo.com 67. Mr Emest KULWA, Secretary to the Deputy Minister of Health, Ministry of Health and Social Welfare, 6 Samora Avenue, I i478, Dar-es-Salaam, Tanzania- Email: depminhealth@gmail.com Twentieth Session of the Joint Action Forum (JAF20), Addis Ababo, December 2074 L4 Top 68. Dr Koffi Potchoziou KARABOU, Coordonnateur, Programme National de Lutte contre l'Onchocercot",B_! a_!1,_P-RS/Kara, Togo -Tdl: (228)2660 lTlO/228 260 600035 - Mobile: (228) 9002 4795 -Fax: Q28)2660 0414, E-mail: karaboup@yahoo.fr Ueanda/Oueanda 69. Hon. Sarah OPENDI, Minister of State for Health (Primary Health Care), Ministry of Health, p.O.Box 7272, Kampala, Uganda - Fax: 256414231584 - Tel. 2564t4 ZitOSl - Email: sarah chns@yahoo.com 70. Dr Edridah Muheki TUKAHEBWA, NTD National Programme Manager, Vector Conhol Division, Ministry of Health, p.o. Box 1661, Kampah, 0ganda - nax: zse 4142 53044 - T el. i +2 5 6'7 7 24 43 6 59 I +2 5 6 4 r 4 -25 1927 - E-mair: ed muheki@smail. com 71. Mr Gabriel Kayiira MATWALE, Program Manager for Lymphatic Filariasis Elimination, Vector Control Division, Ministry of Health, l5 Bombo Road, P.O. Box 1661, Kampala, Uganda - Te1 + 256 414 251 927 - Mob. + 2s6 772 487 431- Email: gkmatwale@gmail.com DONORS/DONATEURS ADB Dr Maimouna DIOP LY, Physician/Principal Health Analyst, African Development Bank (ADB), CCIA Building, Avenue Jean Paul II, 0l BP 1387, Abidjan, C6te d'Ivoire - Tel Office: +225 2:,0 26 42 I I - Mobile: +225 77 22 79 29 - E-mail: m.dioply@afdb.org 72. Japan 73. Dr Toshiki AWAZAWA, Counsellor-Medical Attach6, Ministry Japan, PO Box 5650, Addis Ababa, Ethiopia - Fax : 251 I I 551 5 5 I I 088 - Email: toshiki.awazaw a(dmofa.so.io of Foreign Affairs, Embassy of 1350 - Tel.: 091| 200 722 /251 France 74. Kuwait 75. Dr Christian TOSI, Conseiller R6gional de Coopdration en Santd, Ministdre des Affaires dtrangdres, Ambassade de France, Barclays plaza 15" Floor, p.o. Box 417g4,00100 Nairobi, Kenya - Tel. 00 254 713 513 986 - Email : christiantosi@vahoo.fr Dr Abdul-Redha BAHMAN, Agricultural Advisor, Kuwait Fund Development, P.O. Box 2921, Safat 13030, Kuwait 13030 - Tel: direct +965 22999 190 - Email: bahman@kuwait-fund.org Twentieth Session ofthe lointAction Forum (lAF2O), Addis Abobo, December 2074 15 for +965 Arab Economic 22999186 - Fa+: ?6. Dr Hani AL-GHAWAS, Engineering Adviser, Kuwait Fund for Arab Economic Developmeng P.O. Box 292l,Safat 13030, Kuwait 13030 - Tel: direct +965 22999164 - Fax: +965 22 999 190 - Email: halghawas@kuwa it-fu nd.org Merck & Co. Inc. 77. Dr Janet VESSOTSKIE, Director, Corporate Responsibility, Merck, One Merck Drive, WS2A-56, Whitehouse Station, NJ 08889, USA, Tel: + I 908 399 2978 - Email: vessotsk@gmail'com ianet.vessotskie@merck.com 78. Ms Willemijn ZAADNOORDIJI! Program Manager, Merck, One Merck Drive, L'ancienne route 42A, l2l8 Genev4 Switzerland - Tel. 41 79 593 17 4l Email: wi llenijr.zaadnoordiih@merck.com 79. Johannes wALTZ,Merck KGaA, United Kingdom - Email: iohwaltz@aol.com MITOSATH 80. Dr Francisca Onyekachi OLAMUU, Executive Director, MITOSATH,42046, Mun-Gyel, Behind WAEC Offrce, p.O. gox 205, Jos, Plateau State, Nigeria, Mobile: (234) 80333 18085 - Fax: (234) 7 3 46 47 92, Email: m itosath@hotmail. com ; fr anc iscauk@hotmai l'com Sabin Vaccine Institute 81. Dr Neeraj MISTRY, Managing Director for Global Network of Neglected TroPical-Diseases, Sabin Vaicine Institute,2000 Pennsylvania Ave, NW Suite 7100, Washington, DC 20006, USA - Fa:<: 202-842:7689 - Tel. (work) 2028425025 Mobile: 6466443864 Email: kal in.petkov@sabin.org Sightsavers 82. Dr Caroline HARPER, Chief Executive Officer, Sightsavers, 35 Perrymount Road, Haywards Heath, West Sussex, RHl6 4BX, United Kingdom - Isl +44 7768 640179 - Fax: +44 1444 446 688 - E-mail: charper@sightsavers.org 83. Mr Simon BUSH, Director, Neglected Tropical Diseases (NTDs), Sightsavers, Densu Point, 3d Wawa Avenue, North Dzorwulu-, P.O. Box 30x KIA 18190 Airport, Accra, Ghana - Tel: +8720 O2O3 4OO 720 -Fax: +233 302 780 227 - Email: sbush@siehtsavers'ors 84. Dr Elizabeth ELIIASSAN, Technical Director, NTDs, Sightsavers, Densu Point, 3'd Wawa Avenue, North Dzorwulu, Accra, Ghana -Tel: +233264435933 - Fa;r: +233 302780 227 - Email: eelhassan@sishtsavers.ors g5. Dr Suzar Frances WALKER, NTD's Advisor, Sightsavers, 35 Perrymount Road, Haywards Heath, Wesr Sussex, RHl6 4BX, United Kingdom - Tel: +44 79 89 550714 I +44 (0) 1444 446701 - prv; +44 lM4 446 688 - E-mail: swalker@sightsavers'org Twentieth Session oJ the Joint Action Forum (JAF20), Addis Abobo, December 2074 16 86. Dr Thoko POOLEY, Director of Institutional Funding, UK Office - 35 Perrymount Road, Haywards Heath, West Sussex, RHl6 3BW - Tel. : +44 78ZB O2S 879 - E-mail: tpoolev@si shtsavers.ors Mq Helen I{AMILTON, Policy Advisor NTDs, UK office - 35 perrymount Road, Haywards Health, West Sussex, RHl6, 3BW- Tel.+44 7886 584 989 - Email: hhamilton@sightsavers.org Dr Sunday ISTYAKU, country Director, I Golf course Road, p.o. Box 503, Kaduna, Nigeria - Tel. : +234 8033109465 - E-mail: sisiyaku@siehtsavers.org USAID Ms. Emily Wainwright, Senior Operations Advisor, Neglected Tropical Diseases, USAID, GH/HION/ID, Room 3.07-36 RRB, 1300 Pennsylvania Avenue, NW, washington, DC 20005, USA -Fa<: +1.202216 3702 -TeL.202712 5403 - E-mail: ewainwright@usaid.gov Dr Darin Evans, Technical Advisor for Onchocerciasis and Schistosomiasis, NTD Program, U.S. Agency for International Development, l30l Pennsylvania Avenue, NW, Washington,bc 2OOO5, USA - tel.262 808 3895 - Email: daevans@usaid.gov World Bank 91. Dr Andy Chi Tembon, Senior Health Specialist, HNP Global Practice, The World Bank, Mailstop Jl0-1004? lSlE H Street NW, Room Jl0-142, Washingon,DC20433 - Tel (Office): l-202-458- 87. 88. 89. 90. 4879-Mobile+1703501 0597 Email: Atembon@worldbank.orp - Fax: l-202473-8216 NGDOs/ONGD Carter Center 92. Dr Frank Oliver RICHARDS, Director, River Blindness Elimination and LF Elimination Programs, The Carter Center, 453 Freedom Parkway, Atlanta, GA 30307, USA - Fax: +l 404 420 3881 - Tel: +l 404 420 3898 - Email: frank.richards@emorv.edu Charitable Societv for Social Welfare (CSSW) 93. Dr Abdulmajid Abdulqawi Ferhan AL-[{AMIDI, Secretary General, Charitable Society for Social Welfare (CSSW), Westem Ring Road, New University Intersection, P.O. Box 13i54, Sana'a, Republic of Yemen, Fax: +961-1464399 - Telephone : +967-1464402 - E-mail: afarhan20O5@vahoo.com; info@csswyemen.ors 94. Mr Isameldin Awad Elhussien SALAH, NTDs Program Director, Charitable Society for Social welfare (cssw), Yemen - Tel: 0096't-733843349 - Fax: 00967-t-464390 - E-mail: info@csswyemen.org; arto 1s2002 @yahoo.com Twentieth Session olthe Joint Action Forum pAF2O), Addis Ababo, December 2O74 L7 CBM 95. Prof. KH Martin KOLLMANN, CBM Senior Advisor for NTDs (SANTD), CBM Central Africa Regional Office, P.O. Box 58004 - 00200 City Square, Ring Road Parklands, Nairobi, Kenya - Fa<:*254-20.3740305-Tel.:+254-733524436-E-mail:khm.kollmann@.gmail.com GlaxSmithl(ine 96. Mr Andy WRIGHT, Vice President, Global HealthProgrammes, GlaxoSmithKline, GSK House, 851.19, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom - Tel: +44 7768 23796l - E-mail: Andv.I.Wright@gsk.com 97. Ms. Minne Iwamoto, Director, Africa Malaria Partnership, Global Health Programmes, GlaxoSmithKline, 5 Crescent Drive, NY 0200, Philadelphia, PA l9l12, USA Tel: I 215 751 7096,M: +l 215 280 8387 - For: I 215 751 4046,E-mail: minne.h.iwamoto@gsk.com Helen keller Intemational 98. Nick KOURGIALIS, Vice President, Helen Keller International, Eye Health, 352 Park Avenue South, New York, NY USA 10010 -Tel.:212 532 0544 x 813 - Email: nkoureialis@hki.org gg. Dr Yaobi ZHANG, Africa Regional NTD Advisor, HKI Regional Office for Africa, Dakar, Senegal -Tel. ++447888801010 - Email: yzhang@hki.org 100. Ms Emily Heck TOUBALI, Senior Program Manager, NTD, HKI HQ, ll20 206 Street NW, suite 500N, ICRW, Washington, DC 20036, USA - Tel: +l 202 469 8734 - Email: etoubali@hki.ors IMA World Health l0l. Dr Deogratias DAMAS, Senior Program Manager, MA World Health, 1730 M Street, NW, Suite 808, Washington, DC 20036 Tel. +202'350-3075 Email: deosratiasdamas@imaworldhealth.org lO2. Ms Sarah CRACIUNOru, Senior Program Manager, IMA World Health 1730 M Street, NW, Suite 808, Washington, DC 20036 - Phone: 202-350'3075 sarahcraciunoiu@ imaworldhealth.org Email: ITVTFGH 103. Dr. Teshome GEBRE, Regional Director for Africa, ITI/IFGH, Addis Ababa, Ethiopia - Tel.: 25191 120 35 24 -E-mail: tgebre@Jaskforce.org Twentieth Session oJ the Joint Action Forum 0AF20), Addis Ababo, Decembet 2074 18 Light for the World Dr Amir KELLO, Senior Adviser/Ophthalrnologist, Light for the World, Bole Road, Bedesta Bldg, Addis Ababa, Ethiopia - Fa<: +251115580451 - Tel: + 09ll 4t 65 2t - Email: a.bedri@light-for-the-world.org Lions Clubs Intemational Foundation (LCIF) 104. Dr Mohama TCHATAGBA, Regional Program Specialist, Lions Club Intemational Foundation, Africa & Middle East, 300 West 22'd Street, OakBrook, IL 60523-8842, USA - Fax: 630-706- 917 8 - Tel. : 630-468 4825 - E-mail: Mohama.Tchataeba@lionsclubs.org Mectizan Donation Program MDP) 105. Dr Adrian Dennis HOPKINS, Director, Mectizan@ Donation Program (MDP), 325 Swanton Way, Decatur, Georgia 30030, usA - Tel +l 404-805 7719 - Fa,x: +1.404-371-1138 - Email: ah oo kins @raskforce. ors 106. Dr Yao SODAHLON, Sr Associate Director (Onchocerciasis), Mectizan@ Donation Program (MDP), 325 Swanton Way, Decatur, Georgia 30030, USA - Tel +l.404-388-6172 - Fax: +1404- 371 -l 1 38 - Email: vsodahlon@Jaskforce.org 107. Ms Joni LAWRENCE, Associate Director, Mectizan@ Donation Program (MDP), 325 Swanton way, Decatur, Georgia 30030, usA - Tel +l 7702621683 - Fax: +1.404-371-ll3g - Email: i lawrence@taskforce.org 108. Ms Helen LM, Data Manager, Mectizan@ Donation Program (MDP), 325 Swanton Way, Decatur, Georgia 30030, USA - Tel +1.404-687-5602 - Fax: +1.404-371-1138 - Email: hlim@taskforce.ors OPC 109. Dr Bemard PHILIPPON, Secr6taire G6n6ral, Organisation pour la Pr6vention de la Cdcit6, 17 Impasse d'Al6sia, 75014, Paris, France - Tel : (00331) 40 44 94 041(00331) 44 t2 4190 - Fax : (003 3 I ) 44 12 23 0 l - E-mail: abphilippon@ahoo.fr UFAR ll0. Dr Daniel SHUNGU, Executive Director, UFA& 13 Camation Place, Lawrenceville, New Jersey, USA - Tel. I 609 954 33 98 - Email: dlshunsu@aol.com US Fund for IJNICEF lll. Dr Jason SPERINCII Deputy Director, Integrated Partnerships, U.S. Fund for UNICEF, 125 Maiden Lane, New York, NY 10038 - Tel.: Office: (212)922-2496 - Mobile: (480)272-0261 - Email : i sperinck@unicefusa.org Twentieth Session oI the toint Action Forum (!AF20), Addis Abobo, December 2074 19 World Vision International ll2. Ms Azadeh BAGHAKI, World Vison International, I Vision Drive, Buruood East - Tel. +61432348920 - Email: azadeh.baghaki@.worldvision.com.au I 13. Sean KERRIGAN, World Vison, USA - Tel. 251935401997 -Emaill. sean-kerrigan@wri.ore IIYVTTED PARTNERSiPARTENAIRES IIYVITES Bill & Melinda Gates Foundation ll4. Dr Julie JACOBSON, Senior Program Offrcer, Bill & Melinda Gates Foundation, P.O. Box 23350, Seatrle, WA 98102, USA Tel: +206-770-1672 - E-mail: Julie.Jacob son@eatesfoundation.org ll5. Mr Aryc W. MOSIIER, Program Officer, Bill & Melinda Gates Foundation, P.O. Box 23350 Seattle, WA 98102, USA - Tel +206-225 8758 - E-mail: aryc.mosher@gatesfoundation.org 116. Dr Donald Bundy, Deputy Director NTD, Global Health, Bill & Melinda Gates Foundation, 62 Buckingham Gate, London, SWIE 6AJ, United Kingdom - Tel.44207798 6519 - E-mail: Donald. Bundy@satesfoundation.ore ll7. Dr Sandra Laney, Program Offrcer, Bill & Melinda Gates Foundation, 1432 Elliot Ave W., Seattle, WA 98121, USA - Tel: +l 206-770 2370 - Email: Sandra.Laney@gatesfoundation.ors I18. Ms Ann VARGIIESE, New Venture Fund, NTD Project Manager, 500 5th Ave N, Seattle, WA - Work phone: 773 799 4961 - Mobile: 773 799 4941 - Email: ann.varehese@gatesfoundation.org 119. Ms Catherine GOODE, -Bill & Melinda Gates Foundation, 1432 Elliot Ave W., Seattle, WA98l2l,USA - Tel: +202-812 1899 - Email: Catherine.goode@satesfoundation.org Centers for Disease Control and Prevention (CDC/Atlanta) l2O. Dr LeAnne FOX, Team Lead, Disease Elimination and Control Activity, Divison of Parasitic Diseases, CDC, 1600 Clifton Road, NE, MS A-06, Atlanta, GA 30333 - Fax: 404-7184816 - Tel.(Work) 404 -7 I I 47 39 - Mob ile : 40 4 -27 2'80 I 6 - Emai I : I fox@,cdc. gov CNTD/LSTM l2l. Professor Moses J. BOCKARIE, Professor and Director, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK, Fax: +44 (0) l5l 705 3370, Phone: +44 (0) l5l 705 3343, Mobile: +44 07595020694, Email: moses.bockarie@lstmed.ac.uk: 122. Professor David Hurst MOLYNEUX, Professor of Clinical Medicine, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, United Kingdom Tel: 44-15l-705-3291; +44-7780-991-824 E-mail: David.Molyneux@lstrned.ac.uk Twentieth Session of the JointAction Forum (JAF20), Addis Abobo, December 2074 20 123. Mrs Joan FAHY, Project Manager, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom -Tel: +44 151705 3 I 45 ; Mobile :+44 7 88 072 2087 - E-mai I : Joan.Fahy@lstmed.ac.uk 124. Ms Sara HOLMES, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom Tel: +44 l5l 705 3145; Mobile:+079 719 259 98 E-mail: Sara.Holmes@lstmed.ac. uk 125. Sian FREER, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom Tel: +44 l5l 705 3212; Mobile:+079 122 885 95 E-mail: S ian.Freer@lstmed.ac.uk 126. Dr Louise KELLY-HOPE, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5 QA, United Kingdom - Email: Lou ise.Kelly-Hope@lstmed.ac.uk 127. Prof. Charles MACKENZIE, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom - Tel. 1-5173166566 - Email: rropmed@mac.com 128. Dr Louise FORD, AWOL Consortium/LSTM, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom - Louise.Ford@lstmed.ac.uk DOLF 129. Dr Gary J. WEIL, Professor, Washington University School of Medicine, 660 S. Euclid Ave, Box 8051 st. Louis, MO 63110 USA - Tel: +l 314747 5lgg - Far<: +l 314454 5293 - E-mail: I,wei l@.dom.wustl. edu Dr Peter FISCHER, Washington University, School of Medicine, 4444 Forest Parkway / St.Louis MO 63110 - Tel. 314-647 5091 - Email: pufische@dom.wustld ERASMUS l3l. Dr Wilrna A. STOLK Senior Researcher/Epidemiologist, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040,3000 CA Rotterdam, The Netherlands, Tel: +31 (0) lO7O4 3730 (Dir) / 703 8460 (Secr) - Fax: +31 (0) l0 703 8474 -E-mail: w.stolk@erasmusmc.nl 132. Dr Luc COFFENG, Post-Doctoral Researcher in Infectious Disease Control, Department of Public Health, Erasmus MC University Medical Center, P.O. box 2040,3OOO CA Rotterdam, The Netherlands - Tel.: +31 (0)10 70 M269 (direct) 138464 (secr.) - Far<: +31 (0)10 70 38475 - Email: l.coffene@erasmusmc.nl Institut de Recherche pour le D6veloppement (IRD) 133. Dr Michel BOUSSINESQ, Directeur de Recherche, IRD, UMI-233,911, avenue Agropolis, BP 64501,34394 MonQellier Cedex 5, France, Tel: (33) 67 51 39151 - Fax : (33) a 67 4t 6t 46 -E- mail: michel.boussinesq@ird.fr Twentieth Session ofthe loint Action Forum pAF20), Addis Ababo, December 2074 2t 130. Islamic Development Bank 134. Mr Elbashier SALLAM, Lead Health Specialist, Islamic Development Bank, King Khalid Road, P.O. Box 5925, Jeddah ,21432, Kingdom of Saudi Arabia - Fax: 966 12 646 7828 -Tel.966 5541 58 649 - Email: asallam@.isdb.org Malaria Consortium 135. Ms Jamie TALLANT, Sr Health Specialist, Malaria Consortium, London, Post Rd, Clevelend, GA 30528 - TeI. 706 892 8570 - Email: j.tallant@malaria Modelling Consortium 136. Dr Deirdre HOLLINGSWORTH, Associate Professor in Epidemiology, Coordinator of the newly developed, Modelling Consortium, University of Warwick, United Kingdom, Tel: +44 24 7652 2698 - E-mail : d eirdre.hol linssworth@warwick.ac.uk PATH 137. Dr Gonzalo DOMINGO, Senior Program Officer, PATH, PO Box 900922, Seattle, WA 98109, USA, - FAX 206.285 .6619 -Tel.206 2853500 - E-mail: gdomingo@path.org Task Force For Global Health 138. Dr Eric OTTESEN, Director, Director NTDs Support Center, Task Force for Global Health, 701 l3s Street, NW, Washington, DC 20005-3967,USA- Tel: +1.404 687 5604 - Mobile: 1.404275 0758 - E-mail : eottesen@Iaskforce.org 139. Dr Patrick LAMMIE, Senior Scientist, Task Force for Global Health, 325 Swanton Way, Decatur, Georgia 30030, USA - Tel: +1404.687-5613 - Mobile: + 678209 9126 - Fax: +l-404-562 4193 - Email : plamm ie@Jaskforce.org l4O. Dr Maria REBOLLO POLO, Program Director, Neglected Tropical Diseases Support Center (NTD-SC), the Task Force for Global Health, Atlantq USA - Tel.+ 1404 5921467 - Mobile: + I 404 863 ll79 - E-mail: mrebollo@taskforce.org; mariazyl@hotmail.com l4l. Dr Kisito OGOUSSAN, Associate Director of Mapping Research, Neglected Tropical Diseases Support Center, Task Force for Global Health, 325 Swanton Way, Decatur, Georgia 30030, USA - Tel: +l -404 .687-5633 - Fax: +1404-371-1138 - Email: koeoussan@taskforce.org 142. Dr Steven WILLIAMS, Task Force for Global Health, 325 Swanton Way, Decatur, Georgia 30030, USA - Tel. | 413 320 5991 - Fa:r: I 413 685 3991 - Email: swilliams@taskforce.org Twentieth Session olthe lointAction Forum UAF20), Addis Ababo, December 2014 22 The End Fund 143. Mr Warren LANCASTER, Senior Vice President, The End Fund,4l E I 16 St., I l6 FI, NY, NY - Email: wlancaster@end.org 144. Ms Ellen AGLER, CEO, The End Fund, 4l E. ll'h St. I ln Floor, Ny, Ny 10003, USA - Tel. + l9l7 207 4400 - Email: eagler@end.org 145. Ms Karen PALACIO, Program Director, The End Fund,4l E llth St, FI 10, Ny, Ny 10003 - Tel.: +212 905 6177 - Email: kpalacio@end.org RTI Intemational 146. Ms Lisa ROTONDO, Deputy Technical Director, 701 l3th street NW, Suite 750, Washington DC 20005, USA - Tel.: +l 202 974 7890 - E-mail: lrotondo@rti.org 147. Dr Achille KABORE, Senior Technical Advisor, 701 13th street NW, Suite 750, Washington DC 20004 USA - Telephone : +1202 340 8888 - E-mail: akabore@rti.org 148. Dr Scott MCPFDRSON, NTD Technical Advisor, Control of Neglected Tropical Diseases: ENVISION, RTI International, Global Health Division, Bole Road Addis Ababa, Ethiopia - Tel.: +251937 890969 - Email: smcpherson@rti.org 149. Dr Tigist GETACI{EW, M&E Officer, Control of Neglected Tropical Diseases: ENIVISION, RTI International, Global Health Division, Bole Road Addis Ababa, Ethiopia - Tel.: +251911758001 - Email: tigibest@.vahoo.com; thima.contractor@rti.org OBS ERVERS/OBSERVAT EURS African Filariasis Morb idity Project 150. Dr Sunny Doodu MANTE, Surgical Coordinator, African Filariasis Morbidity Project, Box KB- 282, Korle-Bu, Accra, Ghana- Tel.+233 206300696 - Email: sunnymante44@yahoo.com Briehton and Sussex Medical School l5l. Dr Kebede DERIBE, Research Fellow, Brighton and Sussex Medical School, P.O.2082/1250, Addis Ababa, Ethiopia -Tel.; +251911937708 - Email: kebededeka@yahoo.com Centre for Schistosomiasis and Parasitology 152. Prof. Louis-Albert TCHUEM TCHUENTE, Director, Centre for Schistosomiasis and Parasitology, P.O. Box 7244 Yaound6, Cameroon - Tel.: + 237677707436 - Email: tchuemtchuente@.sch isto.com Twentieth Session of the loint Action Forum (lAF20), Addis Abobo, December 2074 23 Children Without Worms 153. Dr David ADDISS, Director, Children Without Worms, 325 Swanton Way, Decatur, GA 30030, USA - Tel. I 404 5921415 - Email: daddiss@laskforce.ore Disease Control and Prevention. India 154. Mr Chandrakant REVANKAR, Disease Control and Prevention, India, 3ll5ll4, Garden View 50 C, Bhanaui Ngs, Mavol Mumbai40005 - Tel. 9l-9167112530 - Email: Revankarcr@gmail.com Drugs for Neglected Diseases initiative (DNDi) 155. Dr Mhizi A. Belen PEDRIQUE, Epidemiologist, Chemin Louis Dunant 15, 1202 Geneva, Switzerland - Fax: 41229069231 Tel. 33685858672 I 41229069230 Email: bpedrioue@dndi.ore Eisai Inc. 156. Dr Fabian GUSOVSKY, Eisai Inc., 4 Corporate Dr Andover, MA 01810, USA - Tel. 978 837 - 47 24 - Email: fab ian:gusovsky@eisai. com Emory University 157. Dr Danny Haddad, Director Global Ophthalmology, Emory University, 13658 Clifton Rd NE, Atlanta, GA30322,USA - Tel. +14047784606 - Email: dhaddad@emory.edu Federal Universitv of Aericulture. Abeokuta" Nieeria 158. Prof. Uwemedimo EKPO, Federal University of Agriculture, Abeokuta, Nigeria - Tel.234 802 7 5 5 5 689 - Email: ufekpo@h otmai l. com ; ekpouf@.un aab.edu. n e Filariasis Elimination and STH Control Program 159. Dr Rouseli HAQ, Program Manager, Filariasis Elimination and STH Control Program Bangladesh - Email : dr.rouse liha@email.com 160. A S M Sultan MAHMOOD, Technical Coordinator, Program Bangladesh - Email: sveed2 5 @email.com Helen Keller lntemational 16l. Mr Hamado OUEDRAOGO, Programme MTN, Ministdre de la Sant6 - TeL.00226 70 25 79 4l - Email : hamidoub iho@yahoo.fr Twentieth Session ofthe lointAction Forum AAF20), Addis Abobo, December 2074 24 Filariasis Elimination and STH Control 162. Mr Issa GNANDOU, Helen Keller Intemational, BP 82, Niamey, Niger - Tel. (00227) 96 292252 - Email: gnandouissa@yahoo.fr Institute of Tropical Medicine. Naeasaki University 163. Dr Kazuyo ICHIMORI, Institute of Tropical Medicine, Nagasaki University, Sakamoto l-124, Nagasaki 852- 8523, Japan - Email: kazuyoichimori@nagasaki-u.acjp IZUMI Foundation 164. Ms Gretchen Stoddard, Program Officer, I Financial Center, Izumi Foundation, Boston, MA 02lll, USA - Fax :617-292-2315- Tel : 617-292-2333 - E-mail: sroddard@izumi.org JICA 165. Mr Taniyama Yusuke, JICA - Email: vusuke609@gmail.com 166. Ms Matsunaga MIKA, JICA - Email: mikamatsu@gmail.com Kenya Medical Research Institute (KEMRI) 167. Prof. Njeri WAMAE, Chief Research Officer, Kenya Medical Research Institute (KEMRD, P.O. Box 54840 - 00200, Nairobi, KENYA - Tel:+254420-2722541 - Cell: +254-728-592-855 - E- mail : nwamae@kemri.org; gacheric.wamae@gmail.com Prof. Sammy NJENGA, KEMRI - ESACIPAC, Box 54840 - 00200, Nairobi, Kenya - Tel. +254 735 17 33 72 - Email: snjenga@kemri.org LEPRA 169. Ms Sarah NANCOLLAS, Chief executive, Lepra 28 Middleboroogh, Corchester Essex, UK- Tel. 0120 6216700 - Email: sarahn@lepra.orq.uk 170. Mr Paul David WATSON, 29, Brandon Close, Kdlington, Oxon, 0 x 5 IAy - Eamil: odwwork@yahoo.co.uk LF Program/Yemen l7l. Dr Abdul-Samid AL-KUBATI, NFP-Filariasis, LF Program, Ministry of Population and Health, NLEP- P.O.Box 6593 -Taiz, Yemen - Tel. 00967 '171292029 - Fax: 009674 263 651- Email: a- samidku@hotmail.com Twentieth Session of the toint Action Forum pAF20), Addis Abobo, December 2014 25 168. London School of Hygidne & Tropical Medicine 172. Dr Kathrine Halliday, Research Fellow, LSTHTM, Keppel St, London, UK - Email: Katherine.halliday@lshtm.ac.uk MAP Intemational 173. Mr Safari NGOWA, MAP Intemational, P.O. Box 21663 - 00505, Nairobi, Kenya - Tel. +254 7227 17 563 - Email: sngowa@.map.org Ministry of Comon Dev. Mother and Child Health Mr Teday SOKESI, Ministy of Dev. Mother and Child Health, 59820 Riad Lusaka _ Tel. 007 60577 4042 I I - Email: sokted@yahoo.com Ministry of Health - Zambia 174. Mutale Nsakashalo SENKWE, NTO National Coordinator, Ministry of Health, P.O. Box 30205 Lusak4 Zambia-TeL.0977 229 233 - Email: dmsakasenkwe@),ahoo.co.uk 175. Nina Malala MONGA, Ministry of Health, P.O. Box 30205 Lusaka, Zambia - Tel. +260 977 404015 - Email: nina monea@yahoo.co.uk Ministry of Health and Child Care. Zimbabwe 176. Dr Isaac PHIRI, NTD Focal persor/Coordinator NTD, 3029, Daison close New Bluff Hill, Ministry of Health and Child Care, Box Cy 1122, Harare, Zimbabwe - Tel. 263 772 810 580 - Email: drisaacphiri@yahoo.com MSH 177. Dr Greg SMON, MSH, 4301 N. Fairfax Dr Ste 400 Arlington, VA. - Tel. 4102624039 - Email: esimon@.msh.org 178. Aklile Aka-Gabriel Daniel GIORGIS, MSH,430l N. Fairfax Dr Ste 400 Arlington,YA22203 - Tel. 703 310 3462 - Email: gdaniel@msh.ors Mundo Sano l7g. Juan Jose De Los SANTOS, Coordinator, Mundo Sano, Spaim, C/Quintandpaua, 2. 3'd Floor, 28050, Madrid, Spain - Tel. 34618227787 - Email: jgeruqs@mundqlAnoog 180. Dr Arancha Amor, Ethiopia Coordinator, Mundo Sana, Bahir Dar, TeL; +251918158489 - Email: arauduru@gmail.com Twentieth Session oI the lointAction Forum UAF20), Addis Abobo, December 2074 26 l8l. Mr Melaku ANEGAGRIE, Ethiopia coordinator, Mundo sano, p.o. Box 1296 - tel. 251 9l 8708070 - Email: anesaeriemelaku@vahoo.com National Nutrition Institute 182. Prof. Reda RAMZY, Professor "Emeritus" National Nutrition Institute, 2l ELTayef St, Dokki, Cako, 124 I l, Egypt - Tel. 20 1286263 l2l - Email: reda m@masrawy.co m National P. Action Network fNAPAN) 183. Mr BIMI BEYENE, National P. Action Network (NAPAN), Addis Ababa - Tel. 091 1734657 - Email : bim ik@napanethiopia.org Neoal 184. Mr Tulasi Ram ADHIKARI, LF Focal Person (HA), Department of Health Services, Epidemiology and Disease Control Division, Teku, Kathmandu - Tel: +977-014255796 / i$77 9841586982 -Faxi +97741-4262268 - Email: tulas2l0@),ahoo.com and ewarsedcd@gmail.com Nnamdi Azikwe University Awka. Nigeria 185. Dr Chinyelu Angela EKWUNIFE, Public Health Parasitologist, Department of Parasitolory and Entomology, Nnmadi Azikwe University, P/M 5025, Awka, Nigeria - Tel: +234 8035499ti68 -E-mail: drchve@),ahoo.com Papua New Guinea 186. Mr Leo Sora Makita, Papua New Guinea, Department of Health, P.O. Box 807, Wagani pNG, Tel. +675 301 3?74 - Fax: + 675 3013760 - Email: leo.makita@gmail.com Parasitology and Public Health Societv of Nigeria 187. Prof. Chinyere UKAGA, Public Health Parasitologist, University Professor (Academia), Deparfrnent of Animal & Environmental Biology, Imo State University Owerri, P/TVI 2000, Owerri, Nigeria - Tel. +234 8068254576 - Email: chinyukaga@yahoo.ocm Private Person (chair of GAELF session) 188. Dr Yankum DADZB,, Retired wHo stafl p.o. Box os-1905, Accr4 Ghana Tel. +233208239350 - Email: yankumdadzie@iname.com Twentieth Session ol the !oint Action Forum pAF20), Addis Abobo, December 2074 27 RPRG/WHOAVPRO-ManiIa Offi ce 189. Dr. C.P. RAMACHANDRAN, Professor Emeritus Dato, Member-RPRG-WPRO-WHO-OFFICE Manila and Retired Chair of RPRG-WPRO , 8a44, Belvedere Condo., l/63, Jalan Tunku, Bukit Tunku, 50480-Kuala Lumpur - Malaysia - Fax: 00-603-26986152 - Tel: 00-603-26987275 - Email : ramacp@hotmail.com The Lepresy Mission Intemational 190. Dr Yousif DENG RIAK DENG, The Lepresy Mission International Email: yousifd@tlmsudan.rg; yousifdr@gmail.com WHO/APOCAJNAAB Blackfly Multi.Country Mieration studies 19 I . Dr Sammy Sam-Wobo, Principal Investigator / Associate Professor, Department of Biological Sciences, Federal University of Agriculture, Abeokuta, Nigeria Tel.: 23 48033 19931 5 - Email: sammywobo@.gmail.com University of Benin Teaching Hospital lg2. Dr Ehizogie Egbeobauwaye ADEYEMI, Medical laboratory Scientist, University Of Benin Teaching Hospital, Department of Histopathology and Morbid Anatomy, PMB lll, Ugbowo, Benin City, Edo State - Tel.: +2348057198449 - Email: aehiozoeie@yahoo.com University of Buea lg3 . Prof. Samuel WANJI, Head of Department of Microbiology and Parasitology Faculty of Science University of Buea, P.O. Box 63, Buea - Cameroon - Work phone: 237 77'7 243 84 - Mobile: 237 777 243 84 - E-mail: swanji@.yahoo.fr; samwand.ii@.smail.com lg4. Dr Fanny F. FOMBAD, R2F0TDE, University of Buea, P.O. Box 63, Buea - Cameroon - Phone: 237 675091659 - E-mail: ffffombad@email.com Universitv of Liverpoo I 195. Dr Janet SCOT[, krstitute of Translational Medicine, University of Liverpool, Liverpool, L69 3GE - Tel. 07899822430 - Email: iscott@liverpool.ac.uk Universitv of Malawi 196. Mr Bagrey NGWIRA, University of Malawi, College of Medicine, Pl Bag 360, CHICHIR, Blantyre, Tel. +265 999 554 003 - Email: basreynewira@gmail.com Twentieth Session of the loint Action Forum UAF20), Addis Abobo, December 2014 28 Universitv of Yaounde I 197. Prof. Joseph KAMGNO, Associate Professor, Faculty of Medicine and Biomedical Sciences, University of Yaounde I and Director of Filariasis and other Tropical Diseases Research Centre, BP 5797 Yaounde, Cameroon - Te100237 2222 024 42 - Mobile: 00237 6777 897 36 - Fax 00237 2220 24 43,E-mail : kamgno@crfilmt.org Universitv of Zimbabwe 198. Prof. Nicholas MID.ZI, University of Zimbabwe, 900, Forbes Rd, Watsrfall l, P.O. Box A178, Avondale, Harare, Zimbabwe -TeL.263 779564805- Email: midzinicholas@gmail.com 199. Prof. Takafira MDULUZA, University of Zimbabwe, P.O.Box MP l67,Mt pleasart, Harare, Zimbabwe - Tel. + 263 773 633 682 - Email: tmduluza@yahoo.com WHO/HQ/GENEVA-Olt/$/S IE GE/cE NEVE 200. Dr Dirk ENGELS, Director, NTD Department, World Health Organization (WHOiHe), 20 Avenue Appia, CH-lzll, Geneva 2T,Switzerland - Tel: +41 22791 3824 - Fax: +41 22791 47 77 - Email: engelsd@who.int 201. Dr Gautham BISWAS, Coordinator PCT, World Health Organization (WHO), avenue Appia, CH 12l I Geneva 2T,Switzerland - E-mail: biswasg@who.int 202. Mr. Xavier DANEY, Senior Legal Officer, Office of the Legal Counsel, World Health Organization (WHO), avenue Appia, CH l2ll Geneva 27, Switzerland - Tel: +41-22-?91-1871; Fax: +41-22-7914158 - E-mail: danelx@who.int ; 203. Dr Tony UKETY, Medical Officer, World Health Organization, 20 Avenue Appia, l2l I Geneva 2T,swrtzerland, Tel: +41227911450,Fax: +41 2279r 4869, E-mail: uketvt@who.int 204. Dr Jonathan KING, Scientist, WHOAITD/PCT, World Health Organization (WHO), 20 Avenue Appia, l2ll Geneva 27, Switzerland - Tel: +41-22791 1423 - Fax: gl 22791 48 69 - E- mail: kingi@who.int: WHO-AFRO/OMS.AF'RO 205, Dr Lucien Alexis MANGA, Regional Adviser & Chair of CSA, Regional Office for Africa(WHO/AFRO), Cit6 du Djou6, BP 06, Brazzaville, Congo - Tel: + 4l7g7il54g2 _ Email: mangal@who.int: 206. Dr Benido IMPOUMA, Programme Manager, Regional Adviser, World Health Organization, Regional Office for Africa (WHO/AFRO), Cit6 du Djoud, BP 06, Brazzaville,Congo -T"1, +2q2660 58 80 - E-mail: impoumab@who.int 207. Dr Alexandre TIENDREBEOGO, NTD Monitoring & Evaluation Ofiicer, World Health Organization, Regional Office for Africa (WHO/AFRO), Cit6 du Djou6, Bp 06, Brazzaville, Congo - Email: tiendrebeogoa@.who.int Twentieth Session of the loint Action Forum pAF20), Addis Abobo, December 2074 29 WHO-ETHIOPWOMS-ETHIOPIA 208. Dr Piene MPELE KILEBOU, WHO Representative, WHO Country Office, Addis Ababa, Ethiopia, P. O. Box 3069, Fax: 251ll5514037,Tel: +251 ll5 4451811251 ll 5531550D51 ll 5534777 - GPN 34600 - Email: mpelep@rvho.int; afivcoet@who.int; 209. Mr Pierre LESSIMI, Operations Offtcer, WHO Country Office in Ethiopia, UNECA COMPOUND, P.O. BOX 3069, Addis Ababa - GPN: +47 241 34602 - Mobile: +251-93-599- 8641 - Email: lessimip@.who.int 2lO. Dr Abate MULUGETA, National Professional Offrcer for NTDs, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Fax (251) I 15 514 037 - Tel: (251) l15 448165 (Offrce), GPN 34646 - (251) 9l I 4010 0l (Cellphone) - Email: abatem@who.int 2ll. Mr Wassihun BELAY, NPO, Health Promotion, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Email: belayw@who.int 212. Mr Birhan MENGISTU, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Fax (251) l15 514 037 - Tel. 0912984332- email; birhanmen@yahoo.ocm 213. Mr Tamrat BELETE TADESSE, Finance and Administrative Assistant, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Email: tamratb@who.int 214. Lishan NEGUSSIE, Programme Assistant, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Email: negussiel@who.int 215. Mrs Genet AWEKE BEYENE, Secretary, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Email: awekeg@who.int 216. Mr Teshome DEJENE, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Fax (251) ll5 514037 -Tel.09l2 120024 -email: 217. Mr Truwork TAFESSE, WHO Ethiopia, Addis Ababa, UNECA Compound, P.O.Box: 3069 - Fax (251) I 15 514 037 - Tel. 091 | 697797 - email; eiruwt@yahoo.com WHO-BT]RUNDUOMS-BURUNDI 218. Dr Dismas BAZA,National Professional Offrcer for NTD, APOC Technical Advisor, Boulevard UPRONA, P.O. Box 1450 Bujumbura, Burundi,lsll +257 22 23l702,Cell: +257 77769680, GPN : 33 4 I 0, E-mail: bazad@who. int; d ismas.baza@yahoo.fr SEAROiIYHO 2lg. Mr Ramesh MAIIAJAN, Emeritus-Professor, PGMER. Chandigarh Inaia, WHO/SEARO - Tel.: +91 172 2565628 - Email: indure43@smail.com Twentieth Session ol the Joint Action Forum (JAF20), Addis Abobo, December 2074 30 APOC/SECRETARIAT-SECRETARIAT/APOC 220. Dr Jean-Baptiste ROUNGOU, Director, APOC, Avenue Naba Zombrd No 1473, 0l B.p. 54g, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 22 7? - Fax: +226 50 34 28 75 - Email: roungouj@rryho.int 221. Dr Chris Ngenda MWIKISA, Manager Corporate Service/APOC, Avenue Naba Zombrd N" 1473, 0l B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 4l 04 - Fax: +226 50 34 28 75 - Email: mwik isac@who.int 222. Dr Grace FOBI, Chief, Sustainable Drug Distribution Unit, Avenue Naba Zombre N" 1473, 0l B.P. 549, Ouagadougou, Burkina Faso - Tel: +226 S0 34 29 53 - Fax: +226 50 34 2g 7l,Email: fobis@who.int 223. Dr Frangois SOBELA, Health System Specialist, Avenue Naba Zombrd No 1473, 0l B.p. 549, Ouagadougou, Burkina Faso - Tel: +226 50 34 29 53 - Fax: +226 50 34 2g 75, Email: sobelaf@who.int 224. Dr Afework Tekle HAILEMARLAM, Epidemiologis! Avenue Naba Zombr6 No 1473, 0l B.p. 549, Ouagadougou, Burkina Faso - Tel: +226 50 34 29 53 - Fa,r: +226 50 34 2g 75, Email: teklea@who.int 225. Prof. Daniel BOAKYE, Entomologist, Avenue Naba Zombrd No 1473, ol B.p. 549, Ouagadougou, Burkina Faso - Teli +226 50 34 29 53 - Fax: +226 50 34 2g 75, Email: boakyed@who.int 226. Mr Honorat Gustave ZOURE, Responsible, Biostatistics and Mapping, APOC, Avenue Naaba Zombrd No 1473, 01 B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 Sg - Fa<: +226 50 34 28 75 - Email: zoureh@.who.int 227. MrAsmani BZIMANA, Budget and Finance Offrcer, APOC, Avenue NabaZombr6 N. 1473,01 B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 53 - Fax: (226) 50 34 2g 75 _ Email: b izimanaa@who.int 228. Prof. Sidi Edy AHMEDOU, Community Ownership and Partnership Offrcer, APOC, Avenue Naba Zombrd N" 1473, 0l B.P. 549, ouagadougou 01, Burkina Faso - Tel: +226 so 34 29 53 -Fax: Q26) 50 34 28 75 - Email: ahmedous@who.int 229. Mr Yacouba ISSAKA NIANDOU, Information System Officer, APOC, Avenue Naba Zombrd N" 1473,01B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 53 - Fax: QZ6) 50 34 28 75 - Email: niandouy@who.int 230- Mr Yaovi AHOLOU, Programme Officer, APOC, Avenue Naba Zombr6 No 1473, B.p. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 59 53 - Fax: +226 50 34 28 75 - E-mail: aholouy@who.int 231. Mrs Diane Sonia MABIALA, Assistante Voyage et Logistique, APOC, Avenue Naba Zombre N" 1473 , B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 53 - Fax: +226 SO 34 2g 75- Email: mabialad@who.int Twentieth Session ofthe tointAction Forum (tAF20), Addis Abobo, December 2074 31 232. Mrs Ida Lda SAVADOGO, APOC Director's Assistant, Avenue Naba Zombr6 N" 1473, B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 53 - Fax: +226 50 34 28 75- Email: savadogoli@who.int 233. Mrs Elise DIALLO, Secretary, Avenue Naba Zombrd No 1473, B.P. 549, Ouagadougou 01, BurkinaFaso-Tel: +22650342953-Fax:+22650342875-Email:palenfoe@who.int 234. Mrs Alima M'BOUTIKI, Secretary, Avenue Naba Zombr6 No 1473, B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 53 - Fax: +226 50 34 28 75- Email: ouattaraal@who.int 235. Mrs Marie Rose KABORE, Administrative Assistant, Meetings, Avenue Naba Zombr6 No 1473, B.P. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 53 - Far: +226 50 34 28 75 - Email: ouedraogor@who.int APOC TECHNICAL CONSIJLTATIVE COMMITTEE 236. prof. Mamoun HOMEIDA, P.O. Box 12810, Khartoum, Sudan - Tel: +249183227599 - Fax: +249183224799 - E-mail: amst33 @hotmail.com TRANSTTION TASK FORCE (TTF) 237. Prof. Thomas R. UNNASCH, Global tnfectious Diseases Research Program, Department of Global Health, College of Public Health, University of South Florida, 3720 Spectrum Blvd., Suite 304, Tampa, PL 33612, Florida, USA- Phone: 813-974-0507/7807 - Fax: l-813-974-0992 - Email : tunnasch@health. usf.edu INTERPRETERS/INTERPRETES 238. Mr Emmanuel PETROS, Addis Ababa, Ethiopia- Email: emmanuelpetros@gmail.com 23g. Ms Genevidve CLEMENT, Le Parc du Jura, 42 avenue du Jura, F-01210 Femey-Voltaire, France - Tel: +33 456820578- Email e.clement@club-internet.fr Z4O. Mrs Safi6tou BARRY, 09 B.P. 526 Ouagadougou 09, Burkina Faso - Tel: (+226) 50 37 74 14 82, Cellulaire (+226) 70 21 4l 14 I 78 03 64 55 Email: safia barry@yahoo.fr; barr.vs afi etou @g mai L c o m 241. Mr Victor IMBOUA-NIAVA, 16, Tantra Link North Kaneshie, Accra, Ghana - Res/Off: (233-30) 2ZZ 6gtt - GSM: (233-27) 521 0790; Q33-24) 4733 0068 - E-mail: vimbouaniava@vahoo.com; v. imboua-niava@aiic.net 242. Ms Maria TED(EIRA, 1283 Prima Vista Estate, Dereham Drive, MulbartonExt.2,ZA-2055, Johannesburg, South Africa - Fax: +27 86 566 6831 - Cell: +27 82 652 3563 - Email: maria@fast.co.za 243. Ms Maria Eduarda FORDHAM, Rua Dr Egas Moniz, 2-2D; Estoril,2765'218, Lisbon, Portugal - Email : memfordham@gmail.com Twentieth Session ol the Joint Action Forum (!AF2O), Addis Abobo, December 2074 32 244. Mrs. Kathryn Jane WATSON, Interpreter, Av. Infante D. Henrique 723,PT-2750-170 Cascais Lisbon, Pornrgal - Tel/Fax: +351-214 820 856 - Mobile : +351-962337 669 - E-mail : kathrynwatson43 @gmai l.com 245. Isabel Catalano, Portuguese<>English Translator/Interpreter, SATI Accredited Interpreter Swom Translator, MA Translation (Wits) - Fax:+27 12347 4646 - Mobile: +27 g2920 2327 - Tel: +27 12 347 9710 - Email: icc@iafrica.com TRANSLATORS/TRADUCTEURS 246. Dr Raogo Augustin KMA, Translator, APOC, Avenue Naba Zombrd No 1473, 0l B.p. 549, Ouagadougou 01, Burkina Faso - Tel: +226 50 34 29 59 - Fax: +226 SO 34 2g 75 _ Email: kimar@who.int 247. Mr Ntsama ONANA, Translator, WHO/Regional Office for Africa, BP 6,Brazzaville, Congo - E- mail : onanan@who.int 248. Mr Samuel Odame BAMFO, Translator, c/o Dr Danso Bamfo, Korlebu Hospital, p.O. Box 197, Kor lebu, A ccra, Ghana - Email : od ames2 002 @,vah oo.co. uk RAPPORTEURS 249. Professeur Soungalo TRAORE, Coordonnateur du Programme National de Lutte contre I'Onchocercose (PNLO), Ministdre de la Santd, 03 BP 7009, Ouagadougou 03, Burkina Faso - Tel: +2267026 06 7l- E-mail: pefoungo@yahoo.fr 250. Mr Tom Luroni LAKWO, Senior Entomologist, National Coordinator, National Onchocerciasis Control Programme (NOCP) Secretaria! Minisfy of Health, P.O. Box 7272,Kampala, Uganda -Tel: +256414-348332 - Fax: +256414-348339 - Email: tlakwo@gmait.com 251. Mr Chukwu OKORONKWO, National Onchocerciasis Control Programme (NOCP), Federal Ministry of Health, Federal Secretariat Phase trI, P.O. Box 083, Garki, Maitama-Abuja, Nigeria -Tel: +234 80 33 61 98 94 - E-mail: chukwu@gmail.com; chukoro christ@),ahoo.co.uk 252. Dr Paul Franck SINTONDJI, Conseiller Technique APOC, Bureau OMS N'Djam6na, euartier AI\4DJAIL{SS -1032 rue du 26 ao0t, B.P. 152, N'Djam6na, Tchad, T6l: 00 235 66 46 06 59 ou sur le GPN 34036, E-mail : sintondjip@who.int: sintofranck@Jahoo.fr 253. Dr Alphoncina Masako NANAI, Technical Adviser, WHO Office for Tat:zania Luthuli Road, P.O. Box 9292,Dar-es-Salaam, Tarzania,Tel: (255) 754270 608, E-mail: nanaia@who.int 254. Dr Frangois MISSAMOU, Coordonnateur National, Programme de lutte contre l'Onchocercose & Chef de Service MTN, Direction de l'Epiddmiologie et de la Lutte contre la Maladie, Ministdre de la Sant6 et de la Population, B.P. 1066, Bra,zaville, R6publique du Congo -Tel: +242 06 66805 63; +242 05 525 4941 - E-mail; francmissamou2O09@smail.com 255. Dr Olga Nelson AMIEL, National Coordinator for NTD, Program Manager of LF, Ministry of Health, Maputo, Mozambique - Tel. 258 827395150 - E-mail: olgaamiel@vahoo.com.br Twentieth Session ofthe tointAction Forum (JAF20), Addis Abobo, December 2074 33 256. Dr Nzuzi KATONDI, Conseiller Technique MTN, Organisation Mondiale de la Sant6 (OMS), Rua Major Kanhangulo, no.l97, C.P.3243, Luanda, Angola, T6l.: QaD 222 33 23 98 ; Fa:<: (244)222 33 23 14; E-mail : renatonzuzistar@gmail.com; katondin@.who.int MEDIA/COMMUNICATION 257. Ms Loza Mazsfin TESFAYE, Communication Officer WHO Country Office in Ethiopia - E- mail : tesfaye l@,who. int 258. Mr Souleymane KONE, Health Information and Promotion Officer (HIP), World Health Organization, 0l BP 2494 lr,lbidjan 01, C6te d'Ivoire - Tel: +225.22.51.72.00 - Fax: +225.22.51.72.32 - Cell: +225.07.14.83.93 - E-mail: kones@who.int 25g. Mrs Emma KALSANY, Administrative Assistant Communication (AuVCOM), World Health Organization-African Programme for Onchocerciasis Control (WHO - APOC), P.O. Box 549, Ou-agadougou 01, Burkini Faso - Tel: +226 50 34 29 53 - Fax: +226 50 34 28 75 - E-mail: kalsan]'e@who'int CONSULTAI\TS 260. Dr Laurent YAMEOGO, 01 BP 3705, Ouagadougou 01, Burkina Faso - Tel: +226 70 21 43 46 - Email : l-)'ameogonch@Yahoo' fr 26l. Dr Alan FAIRBANK, President and CEO, Fairbank & Associates, 77 Leetes Island Road Guilford, CT 06437-3027, Washington, United States - Email: fairbanka@email.com 262. Dr Ricardo THOMPSON, Senior Researcher Scientist, National Institute of Health, Av' Eduardo Mondlane, 1008, Maputo, P.O. Box 264, Maputo, Republic of Mozambique - Tel: +258 823 060 036 - E-mail: rthompsonmz@smail.com Twentieth Session of the loint Action Forum (JAF20), Addis Ababo' December 2074 34